Zentalis grants stock options for 62,000 shares to three new hires under inducement plan

• Zentalis Pharmaceuticals granted non-qualified stock options covering 62,000 shares to three newly hired employees on Oct. 1, 2026.
• Awards were issued under the company’s 2022 Employment Inducement Incentive Award Plan.
• Options carry an exercise price of USD 2.605 per share, matching the Nasdaq closing price on the grant date.
• Term runs 10 years; vesting spans four years with 25% after one year, then monthly installments over three years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zentalis Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610011710PRIMZONEFULLFEED9838285) on October 01, 2026, and is solely responsible for the information contained therein.